Researchers recently investigated a family affected by RAB39B Parkinson's Disease to understand its complex neuropathology. Initially, they focused on the p.G192R variant, which shows unusual intrafamilial diversity. By studying two affected brothers, scientists observed how genetic mutations manifest differently. For instance, the younger brother presented with neocortical Lewy body disease and significant four-repeat (4R) tau pathology. In contrast, the older sibling exhibited similar tau pathology but completely lacked Lewy bodies.

Mechanisms of RAB39B Parkinson's Disease

Because these findings are unusual for monogenic forms of the disease, they suggest complex underlying mechanisms. Furthermore, laboratory models using patient-derived neurons showed a 50% reduction in RAB39B protein levels. Additionally, this reduction particularly affected the peripheral processes of the cells. Moreover, the loss of this protein appears to drive the accumulation of aberrant alpha-synuclein and tau. Consequently, the research provides support for the role of this variant in co-pathology. Therefore, targeting these pathways might provide new therapeutic avenues for neurodegeneration. However, further work in model systems is necessary to offer deeper insights. Specifically, understanding the interplay between these proteins is vital. Finally, this study highlights the importance of genetic screening in movement disorders.

Frequently Asked Questions

What is the inheritance pattern of RAB39B-related Parkinson's?

This condition follows an X-linked dominant inheritance pattern, often with reduced penetrance in females, meaning carriers may not always show symptoms.

How does the RAB39B p.G192R variant affect brain pathology?

The variant leads to a significant reduction in RAB39B protein and promotes the accumulation of both alpha-synuclein and 4R tau, though findings can vary even within the same family.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Latimer C et al. Heterogenous Neuropathology in a Pedigree with RAB39B-Related Parkinson's Disease. Mov Disord. 2026 May 15. doi: 10.1002/mds.70341. PMID: 42138034.

Mata IF et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Mol Neurodegener. 2015;10:50.

Wilson GR et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology. Am J Hum Genet. 2014;95(6):729-735.